These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17927293)

  • 1. Over-the-counter triptans for migraine : what are the implications?
    Tfelt-Hansen P; Steiner TJ
    CNS Drugs; 2007; 21(11):877-83. PubMed ID: 17927293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-the-counter triptans--making the switch.
    Lancet Neurol; 2005 Oct; 4(10):587. PubMed ID: 16168921
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
    Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
    Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptans for the management of migraine.
    Johnston MM; Rapoport AM
    Drugs; 2010 Aug; 70(12):1505-18. PubMed ID: 20687618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naratriptan: an alternative for migraine.
    Dulli DA
    Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum effect of triptans in migraine? A comment.
    Tfelt-Hansen P
    Cephalalgia; 2008 Jul; 28(7):767-8. PubMed ID: 18547214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan.
    Wang JT; Barr CE; Goldfarb SD
    Headache; 2002 Jan; 42 Suppl 1():38-43. PubMed ID: 11966863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the factors underlying discontinuation of triptans.
    Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
    Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of triptans for migraine headaches during pregnancy and breastfeeding.
    Duong S; Bozzo P; Nordeng H; Einarson A
    Can Fam Physician; 2010 Jun; 56(6):537-9. PubMed ID: 20547518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of a triptan Rx-to-OTC switch in six EU countries.
    Millier A; Cohen J; Toumi M
    PLoS One; 2013; 8(12):e84088. PubMed ID: 24367628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptans and migraine: advances in use, administration, formulation, and development.
    Macone AE; Perloff MD
    Expert Opin Pharmacother; 2017 Mar; 18(4):387-397. PubMed ID: 28129702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the use of triptans in acute migraine.
    Gawel MJ; Worthington I; Maggisano A
    Can J Neurol Sci; 2001 Feb; 28(1):30-41. PubMed ID: 11252291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.